• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 39
  • 22
  • 10
  • 7
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 110
  • 38
  • 35
  • 19
  • 14
  • 14
  • 13
  • 13
  • 12
  • 10
  • 10
  • 9
  • 9
  • 8
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Uttryck av Nfr2 och dess kliniska roll i klarcellig njurcancer / Expression of Nrf2 and its Clinical Role in Clear Cell Renal Cell Carcinoma

Dahmani, Younes January 2012 (has links)
No description available.
32

A Big Response to a “Small” Problem: Identifying the Oxidative Potential of Nanomaterials and the Physicochemical Characteristics That Play a Role

Berg, James Michael 2011 December 1900 (has links)
Nanotechnology as a science is emerging rapidly. As materials are synthesized and utilized at the nanometer size scale, concerns of potential health and safety effects are arising. In an effort to elucidate the physicochemical characteristics of nanoparticles influential in toxicological studies, surface properties of metal oxide and carbonaceous nanoparticles were measured. These properties include zeta potential, dissolution and surface-bound chemical components. Subsequently, the role of these properties in oxidative stress was examined in vitro. This work identifies the influence that pH has on the zeta potential of nanoparticles. The zeta potential has the ability to alter colloidal stability, as the largest nanoparticle agglomerate is seen at or near the isoelectric point for each of the particles tested. Furthermore, it was observed that metal oxide nanoparticles which exhibit a charged surface at physiological pH, lead to decreased in vitro cellular viability as compared to those that were neutral. Thus, nanoparticle zeta potential may be an important factor to consider when attempting to predict nanoparticle toxicity. Real world exposure to nanoparticles is a mixture of various particulates and organics. Therefore, to simulate this particle mixture, iron oxide (Fe2O3) and engineered carbon black (ECB) were utilized in combination to identify potential synergistic reactions. Following in vitro exposure, both nanoparticle types are internalized into endosomes, where liberated Fe3+ reacts with hydroquinone moieties on the ECB surface yielding Fe2+. This bioavailable iron may then generate oxidative stress through intracellular pathways including the Fenton reaction. As oxidative stress is common in particulate toxicology, a comparison between the antioxidant defenses of epithelial (A549) and mesothelial (MeT-5A) cell lines was made. The A549 cell line exhibits alterations in the NRF2-KEAP1 transcription factor system and therefore retains high basal levels of phase II antioxidants. Both cell types were exposed to 33 nm silica where intracellular oxidant generation coupled with markers of oxidative stress were observed. While the MeT-5A cells exhibited a decrease in cell viability, the A549 cell line did not. Therefore, proper characterization of both material and biological systems prior to toxicity testing will help to further define the risks associated with the use of nanotechnology.
33

The Nrf2 transcriptional target, OSGIN1, contributes to the cytoprotective properties of dimethyl fumarate

Brennan, Melanie Shackett 12 March 2016 (has links)
Understanding how defense signaling pathways regulate neuronal protection in the compromised central nervous system (CNS) is essential for combating neurodegenerative disorders. This is apparent in the intrinsic activation of the transcription factor Nrf2 during periods of oxidative stress, a hallmark of neurodegeneration. This regulator of the antioxidant response induces the transcription of genes essential for protecting against oxidative stress-induced damage and is a prime target for drug discovery. Delayed-release dimethyl fumarate (DMF), currently approved for the treatment of relapsing-remitting forms of multiple sclerosis (MS), is believed to mediate its effect via the Nrf2 pathway; however, the exact mechanisms of action are unknown. The primary aim of the studies outlined in this dissertation was to identify the molecular mechanisms of Nrf2 regulation and subsequent cellular protection conferred by DMF and its bioactive metabolite, monomethyl fumarate (MMF). For this thesis study, transcriptional profiling studies following oral administration of DMF were conducted to characterize DMF pharmacodynamic responses in the central nervous system (CNS) and peripheral tissues to understand the functional effects of DMF in vivo as well as explore the necessity of Nrf2 in this process. Data from these studies confirm earlier findings that DMF activates transcription of Nrf2 target genes in the CNS and periphery; however, tissue-specific gene expression was also observed, indicating additional levels of transcriptional control beyond Nrf2 activation. These findings suggest that there may be unique cytoprotective and immunomodulatory capabilities of DMF within specific tissues. In the CNS, a novel Nrf2 transcriptional target gene OSGIN1 was identified to be significantly upregulated following DMF treatment in vivo; however, the contribution of this gene to the pharmacodynamic properties of DMF or MMF has not been previously described. Therefore, the in vitro effects of MMF on OSGIN1 expression were characterized, and the necessity of OSGIN1 in mediating cytoprotective effects against toxic oxidative stress in human astrocytes was evaluated. These data identify a potential mechanism for MMF-mediated cytoprotection in human astrocytes that function in an OSGIN1 and p53-dependent manner. Overall, the experiments described in this dissertation allow for a broader understanding of endogenous cellular protection and how it can be used to combat CNS disorders.
34

AN INVESTIGATION OF POTENTIAL MECHANISMS UNDERLYING CHEMOSUPPRESSIVE EFFECTS OF DIETARY FLAXSEED IN THE LAYING HEN MODEL OF OVARIAN CANCER

Speckman, Sheree Collette 01 May 2016 (has links)
Epithelial ovarian cancer is the most lethal gynecologic malignancy, with a 5-year survival rate of less than 40%. This is due in part to a lack of early detection markers and lack of specific symptoms during early disease. The laying hen is the only accessible animal model which develops epithelial ovarian cancer spontaneously, with features closely resembling the human disease. It has been estimated that approximately 30% of all cancers can be prevented with diet, exercise, and maintenance of an optimal weight, and the chronic low-grade inflammation that accompanies obesity is implicated as a causal factor in the development of cancer. Flaxseed, a rich plant source of anti-inflammatory omega-3 fatty acids and lignans which act as phytoestrogens and antioxidants, exhibits chemosuppressive effects against the development and progression of ovarian cancer. We have shown that a diet of 10% flaxseed reduces the incidence and severity of ovarian cancer when fed to laying hens over 4 years, due in part to the ability of flaxseed to suppress the production of proinflammatory PGE2 in the ovary by decreasing expression of COX enzymes. To investigate other potential specific mechanisms by which flaxseed acts to suppress ovarian cancer, we examined expression and activity of pathways known to be involved in the etiology and progression of human epithelial ovarian cancer in ovarian cancer in the laying hen, and determined whether flaxseed affected these pathways during cancer development. We investigated the effect of flaxseed and its individual components upon oxidative stress in the normal ovary and in ovarian cancer by analyzing expression of target genes of the NRF2 transcription factor. The NRF2 pathway is a "master switch" that regulates expression of ROS-responsive detoxification genes. Results revealed that expression of four genes was significantly downregulated in then ovaries of hens on the defatted flaxmeal (DFM) and whole flaxseed (WF) diets compared to hens on diets that are high in pro-inflammatory omega-6 fatty acids, suggesting that flaxseed decreases oxidative stress in the ovary. Conversely, one target gene was upregulated in ovarian cancer compared to normal ovaries, and this observation was not affected by flaxseed. Additionally, nuclear accumulation Nrf2 protein was not observed in tumor cells, suggesting that flaxseed does not exert chemosuppressive effects by modulating NRF2 signaling in ovarian cancer. To further investigate pathways potentially regulated by flaxseed, we performed a microarray with 44k features and found that a set of genes involved in branching morphogenesis was upregulated in ovarian cancer and significantly decreased by flaxseed, including E-cadherin and miR-200, suggesting that flaxseed impedes the activity of an aberrantly activated developmental program that controls gland formation during ovarian cancer progression. Lack of nuclear accumulation of ZEB1 protein in tumor cells suggests that this decrease in expression is likely not due to EMT. Finally, due to its known roles in controlling developmental programs such as EMT as well as regulating cell growth and proliferation, we performed a set of experiments to examine activity of the TGF-beta pathway. PCR array analysis revealed that SMAD target genes, ligands, receptors, and co-regulatory proteins were upregulated in ovarian tumors from hens on both diet groups, suggesting TGF-beta signaling is enhanced in ovarian cancer. However, expression of SMAD6 and SMAD7 was upregulated in tumors from hens on the flaxseed diet but not control diet, with SMAD7 protein being expressed in both epithelial tumor cells and intratumoral stromal cells. Additionally, immunohistochemical staining for pSMAD2/3 was decreased in epithelial tumor cells and absent from intratumoral stromal cells in tumors from hens on the flaxseed diet compared to tumors from hens on the control diet, and these data together suggest that flaxseed may inhibit pro-oncogenic TGF-beta signaling in ovarian cancer. Finally, flaxseed prevents the downregulation of expression of p15 and the upregulation of CCNA and CCNE in ovarian tumors, suggesting that flaxseed may slow cell cycle progression. Data from these studies provides preliminary evidence that flaxseed exerts pleiotropic effects upon gene expression to negatively regulate pathways driving the progression of ovarian cancer, including aberrant TGF-beta signaling and glandular development. These studies provide groundwork for in vitro studies to test the specific effects of flaxseed upon proteins involved in TGF-beta signaling and upon the expansion of tumor epithelia.
35

Nouveaux inducteurs covalents de la voie de signalisation Keap1/Nrf2/ARE

Deny, Ludovic January 2016 (has links)
Le stress électrophile et oxydant est un souci grandissant pour la santé avec l'évolution de nos modes de vie. L'exposition aux ultraviolets, à la pollution, aux substances carcinogènes, à la fumée de cigarette et la pratique intensive d'activités sportives sont autant de causes de stress oxydant pour l'organisme. Ces dommages sont associés à plusieurs maladies et conditions pathologiques telles que cancers, diabètes, infections pulmonaires et maladies neurodégénératives. L'élément de réponse antioxydant (ARE) est un des composants principaux des défenses de la cellule contre ce phénomène. Ce promoteur agit sous le contrôle de Nrf2 (Nuclear factor erythroid 2-related factor 2). Une stratégie populaire pour l'activation de ce mécanisme est l'utilisation d'inducteurs covalents. Ces molécules agissent par la formation de liens covalents avec les nombreux résidus cystéine de Keap1 (Kelch-like ECH-associated protein 1), une protéine chaperonne qui contrôle l'activité de Nrf2. Cette thèse présente la synthèse, les propriétés biologiques et l'étude des relations structure-activité d'une librairie d'électrophiles capables d'induire la transcription des gènes cibles de la voie de signalisation Keap1/Nrf2/ARE. Le premier volet fait état de la comparaison d'une variété d'électrophiles simples pour étudier les préférences de la cible. Le deuxième volet montre que la présence d'une seconde fonction capable de piéger un résidu cystéine fournit des analogues très puissants.
36

Cooperative regulation of autophagy by oncogenic PI3-kinase and NRF2 signaling pathways

Guthlein, Caitlin Margaret 17 November 2021 (has links)
Lung cancer is the leading cause of cancer death worldwide with 2.2 million new cases diagnosed and 1.8 million deaths per year. Lung squamous cell carcinoma (LSCC) is an aggressive histological subtype of non-small cell lung cancers (NSCLC), which is strongly associated with cigarette smoking and exposure to environmental pollutants. In collaboration with the Computational Biomedicine group at Boston University, we identified several putative cancer driver mutations in benign premalignant lung tumors, extracted from upper bronchial airway epithelium. The gene mutations from premalignant tumors are thought to initiate neoplasia but cannot promote malignancy independently. It is hypothesized that additional cooperating mutations will have a compounding effect on tumorigenesis if co-expressed in the same tumor cell. We used cancer genomics data from LSCC primary tumors in the Cancer Genome Atlas (TCGA) database to identify lung pre-malignancy associated genes that are significantly co-mutated. Two of the identified mutant genes, PIK3CA and NFE2L2, were shown to co-occur at a statistically significant rate in LSCC primary tumors. The PIK3CA gene encodes the PI3K lipid kinase, which regulates the AKT and mTOR kinase signaling pathways, thus promoting cell proliferation and survival. NRF2, the product of NFE2L2 gene, is a transcription factor that regulates the antioxidant response, playing a protective role against oxidizing cellular damage. NRF2 promotes the transcription of key proteins in the antioxidant response such as glutathione S transferase and NADPH oxidase. NRF2 is normally subject to ubiquitin-mediated degradation, which is regulated by the KEAP1 protein. Loss of function KEAP1 gene mutations are common in lung cancer. When cells are exposed to oxidizing agents, KEAP1 is modified by these agents, resulting in release and stabilization of NRF2, and the subsequent transcription of antioxidant response genes. Studies of PI3K and NRF2, and their downstream effectors have shown that both the PI3K/AKT/mTOR and NRF2/KEAP1 signaling pathways control autophagy, which is a catabolic process that regulates the recycling of macromolecules under conditions of nutrient deprivation. PI3K and NRF2 both control the activity of the SQSTM1/p62 protein, which plays a major role in autophagic degradation of cargo proteins. Autophagy has been implicated as a tumor suppressive mechanism. Both PI3K and NRF2 are known to inhibit autophagy in lung cancer cells. Based on the significant frequency of co-occurrence of PIK3CA and NFE2L2 gene mutations in pre-malignant LSCC lesions, we hypothesize that PI3K and NRF2 cooperate to inhibit autophagy to promote LSCC progression. To test our hypothesis, we co-expressed mutant forms of PIK3CA (E545K) and NFE2L2 (T80K) into a non-transformed Human Bronchial Epithelial Cell line (HBEC-3KT). We performed a series of Western Blots to verify PI3K and NRF2 protein expression as well as downstream AKT activation and markers of autophagy pathway activation. mTORC1 is an effector of PI3K and plays a central role in the inhibition of autophagy through the PI3K/AKT/mTOR signaling network. Therefore, we performed Western Blot analysis of samples treated with the mTORC1 inhibitor Everolimus to compare the effects of mTORC1 inhibition on autophagy activation in control, single PIK3CA, NFE2L2 and double mutant HBEC3-KT cells. We observed significant suppression of autophagy in the PI3K/NRF2 double mutant cells. Moreover, the studies also showed that the double mutant cells are more sensitive to anti-proliferative effects of Everolimus compared to control and single mutant cells. Taken together, our studies show that PIK3CA and NFE2L2 mutations cooperate to hyperactivate the AKT kinase and to suppress autophagy pathway activation. This represents a key mechanism of the malignant transformation of benign premalignant LSCC lesions. This warrants further research into the cooperation between PI3K and NRF2 in lung cancer pathogenesis. Our results have important implications both for diagnosis and treatment of LSCC. Though many important advances in the treatment of lung cancer have been made over the past few decades including the use of tyrosine kinase inhibitors (TKIs) such as Erlotinib, there is still much to understand about the biology and mechanisms of the disease.1 Blockers of the T-cell checkpoint, such as anti-PD-1 drugs are currently FDA-approved first lines of therapy for NSCLC. In addition, immunotherapy has shown some efficacy in lung cancer patients.2 Our studies provide rationale for the development of therapeutics that suppress NRF2 and PI3K activity in the treatment of LSCC.3 Since mTORC1 inhibitors cause robust inhibition of PIK3CA/NFE2L2 double mutant cell proliferation, future studies will be aimed at testing combinations of mTORC1, PI3K and NRF2 pathway inhibitors to treat LSCC.
37

<b>STAPLED PEPTIDES AS DIRECT INHIBITORS OF ONCOGENIC TRANSCRIPTION FACTORS</b>

Ramya Modi (16705938) 31 July 2023 (has links)
<p>Basic leucine zipper (bZIP) transcription factors can have an oncogenic role in cancer development. Nuclear factor erythroid related 2-factor 2 (Nrf2) is a bZIP transcription factor that traditionally is thought of as a cellular protector. In normal cells, Nrf2 is only activated after exposure to reactive oxygen species or electrophiles and induces expression of antioxidant and detoxification genes. However, in many cancers (<i>e.g.,</i> lung, pancreatic, and breast) Nrf2 is constitutively activated and is associated with poor overall survival and intrinsic resistance to anticancer therapies. Nrf2 heterodimerizes with transcription factors small musculoaponeurotic fibrosarcoma Maf (sMAF) proteins (e.g., MafG) in the nucleus and binds DNA, inducing transcription of Nrf2 target genes, conferring chemotherapeutic resistance to cancer cells. c-Myc another bZIP transcription factor is often overexpressed in a variety of cancers and acts like a protooncogenic transcriptional regulator. Mutations that drive abnormal MYC expression are the most common cariogenic event in tumor progression. c-Myc heterodimerizes with Max, its obligate bHLH-LZ heterodimerization partner, to form an active transcriptional state and induces DNA transcription. Hence inhibiting the interaction between c-Myc-Max and Nrf2-MafG will not only prevent bZIP heterodimerization but also DNA binding and downstream functions of c-Myc and Nrf2 that promote carcinogenesis. Stapled peptides, with their ability to target large surface area interactions, have shown promise for specifically inhibiting protein-protein interactions. Stapled peptides have improved cell permeability and oral bioavailability when compared to biologics. We have designed and synthesized stapled peptide for Nrf2/MafG interaction inhibition and stapled peptides for c-Myc/Max heterodimerization inhibition. Nrf2/MafG inhibition using the synthesized stapled peptide N1S, was demonstrated by luciferase and fluorescence polarization assays. Overall, we hypothesize that stapled peptides will be an effective therapeutic strategy resulting in decreased chemotherapeutic resistance and cancer cell proliferation.</p>
38

Activation of Nrf2 at Critical Windows of Development Alters Protein S-Glutathionylation in the Zebrafish Embryo (Danio rerio)

Severance, Emily G 20 October 2021 (has links)
Perturbation of cellular redox homeostasis to a more oxidized state has been linked to adverse human health effects such as diabetes and cancer. However, the impact of altering the regulation of redox homeostasis during development is not fully understood. Specifically, this project investigates the role of the Nrf2 antioxidant response pathway and its effect on glutathione (GSH; cellular redox buffer) at critical windows of development. To explore this, we used zebrafish embryos (Danio rerio) as a model due to the function of GSH and the Nrf2 being conserved among vertebrates. We exposed zebrafish embryos to three Nrf2 activators: two antioxidant enhancing molecules: sulforaphane (SFN; 40 µM) and Dimethyl fumarate (DFM; 7µM) as well as the pro-oxidant tert-Butylhydroquinone (tBHQ; 1µM) for 6 hours at critical windows development: 24, 48, 72 hours post fertilization (hpf). Following exposure, we visualized Nrf2 protein levels and glutathionylation rates using immunohistochemistry and confocal imaging. We found that changes in Nrf2 expression were dependent on the tissue type with there being significant changes in Nrf2 when looking at the pancreatic beta cells. Also in the beta cells, exposure to SFN, tBHQ, and DMF were found to increase Nrf2 translocation into the nucleus. Most notably, all three Nrf2 activators significantly altered glutathionylation levels depending on the time-point the zebrafish were exposed. SFN and tBHQ were also found to significantly increase glutathionylation at 48 and 72hpf, but led to a significant decrease at 96hpf while DMF increased glutathionylation at all three time-points. Interestingly, there was little correlation between Nrf2 protein levels and glutathionylation, but zebrafish with a mutated Nrf2 did have significantly different glutathionylation rates than the wild type fish. This suggests that oxidative stress is not the sole regulator of glutathionylation and instead Nrf2 may also be regulating glutathionylation through GSH storage. My data indicate that the effects of Nrf2 activation on Nrf2 levels and glutathionylation depend on the timing of exposure to the perturbing chemicals and the tissue type. Finding these windows of development where redox homeostasis is most sensitive in humans can allow for possible preventative and/or protective measures to oxidative stress during development.
39

Rôle du stress oxydant au niveau hépatique et rénal dans la toxicité de l’uranium après exposition chronique / Role of oxidative stress in liver and kidney in uranium toxicity after chronic exposure

Poisson-Moreau de Lizorieux, Clémentine 20 December 2013 (has links)
L’Uranium (U) est un métal lourd radioactif dispersé dans l’environnement. Du fait de cette présence naturelle mais aussi de ses applications civiles et militaires, la population générale peut être exposée à l’U par ingestion d’eau de boisson ou d’aliments contaminés. Le système pro/anti-oxydant est un système de défense fréquemment impliqué lors d'une exposition aiguë à l'uranium. L’objectif de cette thèse est d’étudier le rôle du système pro/anti-oxydant après contamination chronique à l’U dans le foie et les reins. Après contamination chronique de rats à différentes concentrations d’U, une accumulation dose dépendante de l’U dans les organes -jusqu'à 6 µg/g dans les reins- ainsi qu’une localisation préférentielle de l’U dans le noyau des cellules du tube contourné proximal sont observées. L’absence de néphrotoxicité observée, même à la plus forte concentration, pourrait s’expliquer par le renforcement du système anti-oxydant et notamment l’augmentation du taux de glutathion. L’étude des effets de la contamination à l’U chez un modèle déficient pour Nrf2, facteur de transcription cytoprotecteur impliqué dans la défense anti-oxydante, a mis en évidence une accumulation d’U plus importante chez les animaux Nrf2 -/-. Néanmoins, les effets biologiques de l’U sur le système pro/anti-oxydant ne semblent pas impliquer Nrf2. Par ailleurs, il existe une corrélation entre la localisation de l’U dans des cellules HepG2 en culture et les effets biologiques sur ce système après exposition à de faibles concentrations d’U. Ce radionucléide se localise dans les noyaux sous forme soluble et l’apparition de précipités est corrélée à la mise en place de mécanismes d’adaptation qui sont ensuite débordés au cours du temps et de la concentration, laissant apparaître une toxicité cellulaire. L’ensemble de ces résultats suggèrent que le renforcement du système anti-oxydant serait un mécanisme d’adaptation après exposition chronique à faible concentration d’U. / Uranium is a radioactive heavy metal found in the environment. Due to its natural presence and to civil and militaries activities, general population can be exposed to U throughout drinking water or contaminated food. The pro/anti-oxidative system is a defense system which is often implicated in case of acute exposure to U. The aim of this thesis is to study the role of the pro/anti-oxidative system after chronic exposure to U in the liver and the kidney. After chronic exposure of rats to different U concentrations, this radionuclide accumulated in the organs in proportion to U intake; until 6 µg.g-1 of kidney tissues. U is localized in nucleus of the proximal tubular cells of the kidney. No nephrotoxicity was described even for the higher U level in drinking water and a reinforcement of the pro/anti-oxidative system with an increase in glutathione is observed. The study of U internal contamination in Nrf2 deficient mice, a cytoprotective transcription factor involved in the anti-oxidative defense has been realized. U accumulate more in Nrf2 -/- mice than in WT mice but the biologic effects of U on the pro/anti-oxidative system did not seem to implicate Nrf2. At the cell level, a correlation between U distribution in HepG2 cells and the biological effects on this system is observed after U exposure at low concentrations. Soluble distribution of U is observed in cell nucleus. The apparition of U precipitates is correlated to the establishment of the adaptive mechanisms overtime which are overwhelmed and lead to a cellular toxicity at higher U level. In conclusion, these results suggest that the reinforcement of pro/anti-oxidative system could be an adaptive mechanism after chronic exposure at low U concentration.
40

Bioinformatic and modelling approaches for a system-level understanding of oxidative stress toxicity / Approches de bio-informatique et de modélisation pour une compréhension du stress oxydant au niveau systémique

Zgheib, Elias 18 December 2018 (has links)
Avec les nouvelles avancées en biologie et toxicologie, on constate de plus en plus la complexité des mécanismes et le grand nombre de voies de toxicité. Les concepts de ‘biologie systémique’ (SB) et de ‘voies des effets indésirables’ (adverse outcome pathway, AOP) pourraient être des outils appropriés pour l’étude de la toxicologie à ces niveaux de complexité élevés. Le point central du travail de cette thèse est le développement d’un modèle de SB du rôle de la voie de signalisation Nrf2 dans le contrôle du stress oxydant. Pour la calibration de ce modèle avec des données expérimentales (exposition des cellules rénales RPTEC/TERT1 à différentes doses de bromate de potassium), plusieurs cycles de proposition/vérification d’hypothèses ont progressivement contribué à l’ajout de nouvelles réactions. Ces nouvelles hypothèses (par exemple : action directe du bromate de potassium sur le DCF, atténuation de la fluorescence du DCF avec le temps, etc.) devraient être confirmées par de futures expérimentations. Ce modèle de SB a été ensuite utilisé pour la quantification d’un AOP de l’insuffisance rénale chronique et comparé à deux autres approches: l’utilisation de modèles statistiques empiriques et celle d’un réseau Bayésien dynamique. Les calibrations des paramètres ont été effectuées par chaînes de Markov simulées MCMC avec le logiciel GNU MCSim avec une quantification des incertitudes associées aux prédictions. Même si la mise au point du modèle SB a été une tâche complexe, la compréhension de la biologie qu’offre ce modèle n’est pas accessible aux deux autres approches. Nous avons aussi évalué les interactions entre Nrf2 et deux autres voies de toxicité, AhR et ATF4, dans le cadre d’une analyse utilisant des données de toxico-génomique provenant de trois projets différents. Les résultats de cette dernière analyse suggèrent d’ajouter au modèle SB de Nrf2 la co-activation par AhR de plusieurs gènes (par exemple, HMOX1, SRXN1 et GCLM) ainsi que d’associer (au moins partiellement) à ce modèle la voie ATF4. Malgré leur complexité, les modèles SB constituent un investissement intéressant pour le développement de la toxicologie prédictive. / New understanding of biology shows more and more that the mechanisms that underlie toxicity are complex and involve multiple biological processes and pathways. Adverse outcome pathways (AOPs) and systems biology (SB) can be appropriate tools for studying toxicology at this level of complexity. This PhD thesis focuses on the elaboration of a SB model of the role of the Nrf2 pathway in the control of oxidative stress. The model’s calibration with experimental data (obtained with RPTEC/TERT1 renal cells exposed to various doses of potassium bromate) comprised several rounds of hypotheses stating/verification, through which new reactions were progressively added to the model. Some of these new hypotheses (e.g., direct action of potassium bromate on DCF, bleaching of DCF with time, etc.) could be confirmed by future experiments. Considered in a wider framework, this SB model was then evaluated and compared to two other computational models (i.e., an empirical dose-response statistical model and a dynamic Bayesian model) for the quantification of a ‘chronic kidney disease’ AOP. All parameter calibrations were done by MCMC simulations with the GNU MCSim software with a quantification of uncertainties associated with predictions. Even though the SB model was indeed complex to conceive, it offers insight in biology that the other approaches could not afford. In addition, using multiple toxicogenomic databases; interactions and cross-talks of the Nrf2 pathway with two other toxicity pathways (i.e., AhR and ATF4) were examined. The results of this last analysis suggest adding new AhR contribution to the control of some of the Nrf2 genes in our SB model (e.g., HMOX1, SRXN1 and GCLM), and integrating in it description of the ATF4 pathway (partially at least). Despites their complexity, precise SB models are precious investments for future developments in predictive toxicology.

Page generated in 0.0474 seconds